Business

TR1 Form

TR1 Form.

articleOxford Biomedica PlcAugust 29, 20135/company/oxford-biomedica-plc/news/tr1-form-2
TR1 Form

About this update from Oxford Biomedica Plc

[{"type":"text","content":"\n \nRNS Number : 7931M Oxford Biomedica PLC 29 August 2013  \n\n\n\n\n\n\n\n\n\n\nTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi\n\n\n\n\n\n\n\n\n\n\n\n\n1. Identity of the issuer or the underlying issuer\nof existing shares to which voting rights are\nattached: ii\n\n\nOxford BioMedica Plc\n\n\n\n\n2 Reason for the notification (please tick the appropriate box or boxes):\n\n\n\n\nAn acquisition or disposal of voting rights\n\n\nX\n\n\n\n\nAn acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached\n\n\n\n\n\n\n\nAn acquisition or disposal of instruments with similar economic effect to qualifying financial instruments\n\n\n\n\n\n\n\nAn event changing the breakdown of voting rights\n\n\n\n\n\n\n\nOther (please specify): \n\n\n\n\n\n\n\n\n\n\n3. Full name of person(s) subject to the\nnotification obligation: iii\n\n\nPrudential plc group of companies\n\n\n\n\n4. Full name of shareholder(s)  (if different from 3.):iv\n\n\nPrudential plc (parent Company)\nM&G Group Limited (wholly owned subsidiary of Prudential plc)\nM&G Limited (wholly owned subsidiary of M&G Group Limited)\nM&G Investment Management Limited (wholly owned subsidiary of M&G Limited)\nM&G Securities Limited (wholly owned subsidiary of M&G Limited)\n\n\n\n\n5. Date of the transaction and date on\nwhich the threshold is crossed or\nreached: v\n\n\n28 August 2013\n\n\n\n\n6. Date on which issuer notified:\n\n\n29 August 2013\n\n\n\n\n7. Threshold(s) that is/are crossed or\nreached: vi, vii\n\n\n<17%\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\n\n8. Notified details:\n\n\n\n\nA: Voting rights attached to shares viii, ix\n\n\n\n\nClass/type of\nshares\nif possible using\nthe ISIN CODE\n\n\nSituation previous\nto the triggering\ntransaction\n\n\nResulting situation after the triggering transaction\n\n\n\n\nNumber\nof\nShares\n\n\nNumber\nof\nVoting\nRights\n\n\nNumber\nof shares\n\n\nNumber of voting\nrights\n\n\n% of  voting rights x\n\n\n\n\nDirect\n\n\nDirect xi\n\n\nIndirect xii\n\n\nDirect\n\n\nIndirect\n\n\n\n\nGB0006648157\n\n\n243,644,738\n\n\n243,644,738\n\n\n239,144,738\n\n\n239,144,738\n\n\n0\n\n\n16.88%\n\n\n0\n\n\n\n\n\n\n\n\n\nB: Qualifying Financial Instruments\n\n\n\n\nResulting situation after the triggerin...

More updates from Oxford Biomedica Plc